CLINICAL_TRIALS
trial_result
· 2022-08-12
Clinical Trial Update: Finding the Optimum Regimen for Duchenne Muscular Dystrophy [Phase 3]
Summary
Phase 3 trial update for Duchenne Muscular Dystrophy evaluating the optimum regimen; study completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Rochester | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: COMPLETED | Results posted: 2022-08-12